Dietary supplements and phytotherapeutic products are widely used in the pediatric population, with use increasing for certain categories of preparations and age groups. These products are frequently used to support growth, strengthen immune defenses, or manage common childhood disorders, and are often perceived as harmless by parents, particularly when they are plant-based. However, children can be particularly vulnerable to the effects of biologically active substances due to their specific physiological characteristics and toxicokinetic differences compared with adults. This thesis evaluates the benefits and risks, with particular attention to toxicological risk, associated with the use of dietary supplements and phytotherapeutic products in children across the entire developmental age range. After outlining the main characteristics of the pediatric population that may influence the absorption, distribution, metabolism, and elimination of substances, the study examines the regulatory framework and the evidence regarding the efficacy and safety of vitamins, minerals, and plant-based products, identifying the conditions under which their use is supported by scientific evidence. Particular attention is given to potential adverse effects resulting from excessive intake of vitamins and minerals, including cases of accidental ingestion or indirect exposure, as well as to the use of melatonin and phytotherapeutic products. Issues related to contamination, adulteration, and variability in the quality of preparations are also addressed. The analysis is complemented by clinical cases and post-marketing surveillance data from the literature concerning documented episodes of toxicity and adverse reactions. The study highlights that the use of dietary supplements and phytotherapeutic products in children requires a careful assessment of the risk–benefit ratio: benefits are better documented in cases of confirmed deficiencies than in healthy children, whereas risks vary depending on the specific nutrient, the quality of the preparation, and the manner of use. Furthermore, the importance of the role of healthcare professionals and the need for dedicated surveillance systems are highlighted, with the aim of promoting the informed and appropriate use of these products.
Integratori alimentari e prodotti fitoterapici sono ampiamente diffusi nella popolazione pediatrica e il loro uso è in aumento per alcune categorie di preparati e fasce d’età. Tali prodotti vengono frequentemente utilizzati per supportare la crescita, rafforzare le difese immunitarie o gestire disturbi comuni dell’infanzia e sono spesso ritenuti innocui dai genitori, in particolare quando sono di origine vegetale. Tuttavia, il bambino può essere particolarmente vulnerabile agli effetti delle sostanze biologicamente attive a causa delle specifiche caratteristiche fisiologiche e delle differenze tossicocinetiche rispetto all’adulto. La presente tesi valuta i benefici e i rischi, con particolare attenzione al rischio tossicologico, associati all’impiego di integratori alimentari e prodotti fitoterapici nei bambini, con riferimento all’intero arco dell’età evolutiva. Dopo aver descritto le principali caratteristiche dell’età pediatrica che possono influenzare l’assorbimento, la distribuzione, il metabolismo e l’eliminazione delle sostanze, vengono esaminati il quadro normativo e le evidenze di efficacia e sicurezza per vitamine e minerali e per i prodotti di origine vegetale, individuando le condizioni in cui il loro impiego risulta supportato da prove scientifiche. Particolare attenzione è dedicata ai possibili effetti avversi dovuti a un eccesso di vitamine e minerali, anche per ingestione accidentale o esposizione indiretta, all’utilizzo di melatonina e prodotti fitoterapici, nonché alle problematiche legate a contaminazioni, adulterazioni e variabilità qualitativa dei preparati. L’analisi è completata da casi clinici e dati di sorveglianza post-marketing presenti in letteratura riguardanti episodi di tossicità e reazioni avverse documentate. L’elaborato evidenzia come l’impiego di integratori e prodotti fitoterapici nei bambini richieda un’attenta valutazione del rapporto rischio-beneficio: il beneficio è meglio documentato nei casi di carenze accertate rispetto al bambino sano, mentre il rischio varia a seconda del nutriente considerato, della qualità del preparato e delle modalità d’uso. Inoltre, viene sottolineata l’importanza del ruolo dei professionisti sanitari e la necessità di sistemi di sorveglianza dedicati, al fine di promuovere un utilizzo consapevole e appropriato di questi prodotti.
Benefici e rischi dell’impiego di integratori alimentari e prodotti fitoterapici in età pediatrica
GARZOTTO, ALICE
2025/2026
Abstract
Dietary supplements and phytotherapeutic products are widely used in the pediatric population, with use increasing for certain categories of preparations and age groups. These products are frequently used to support growth, strengthen immune defenses, or manage common childhood disorders, and are often perceived as harmless by parents, particularly when they are plant-based. However, children can be particularly vulnerable to the effects of biologically active substances due to their specific physiological characteristics and toxicokinetic differences compared with adults. This thesis evaluates the benefits and risks, with particular attention to toxicological risk, associated with the use of dietary supplements and phytotherapeutic products in children across the entire developmental age range. After outlining the main characteristics of the pediatric population that may influence the absorption, distribution, metabolism, and elimination of substances, the study examines the regulatory framework and the evidence regarding the efficacy and safety of vitamins, minerals, and plant-based products, identifying the conditions under which their use is supported by scientific evidence. Particular attention is given to potential adverse effects resulting from excessive intake of vitamins and minerals, including cases of accidental ingestion or indirect exposure, as well as to the use of melatonin and phytotherapeutic products. Issues related to contamination, adulteration, and variability in the quality of preparations are also addressed. The analysis is complemented by clinical cases and post-marketing surveillance data from the literature concerning documented episodes of toxicity and adverse reactions. The study highlights that the use of dietary supplements and phytotherapeutic products in children requires a careful assessment of the risk–benefit ratio: benefits are better documented in cases of confirmed deficiencies than in healthy children, whereas risks vary depending on the specific nutrient, the quality of the preparation, and the manner of use. Furthermore, the importance of the role of healthcare professionals and the need for dedicated surveillance systems are highlighted, with the aim of promoting the informed and appropriate use of these products.| File | Dimensione | Formato | |
|---|---|---|---|
|
Garzotto_Alice.pdf
accesso aperto
Dimensione
1.71 MB
Formato
Adobe PDF
|
1.71 MB | Adobe PDF | Visualizza/Apri |
The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License
https://hdl.handle.net/20.500.12608/117736